GR853063B - - Google Patents
Info
- Publication number
- GR853063B GR853063B GR853063A GR850103063A GR853063B GR 853063 B GR853063 B GR 853063B GR 853063 A GR853063 A GR 853063A GR 850103063 A GR850103063 A GR 850103063A GR 853063 B GR853063 B GR 853063B
- Authority
- GR
- Greece
- Prior art keywords
- compounds
- preparation
- oarylpiperazine
- heter
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8403918 | 1984-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR853063B true GR853063B (el) | 1986-04-09 |
Family
ID=19844955
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR853063A GR853063B (el) | 1984-12-21 | 1985-12-18 | |
GR853065A GR853065B (el) | 1984-12-21 | 1985-12-18 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR853065A GR853065B (el) | 1984-12-21 | 1985-12-18 |
Country Status (14)
Country | Link |
---|---|
US (1) | US4782061A (el) |
EP (2) | EP0190472B1 (el) |
JP (2) | JPS61152666A (el) |
AT (1) | ATE44528T1 (el) |
AU (2) | AU589387B2 (el) |
DE (1) | DE3571436D1 (el) |
DK (2) | DK590085A (el) |
ES (2) | ES8704348A1 (el) |
GR (2) | GR853063B (el) |
IE (1) | IE58916B1 (el) |
IL (1) | IL77396A (el) |
NZ (2) | NZ214612A (el) |
PH (2) | PH23958A (el) |
ZA (2) | ZA859664B (el) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0190472B1 (en) * | 1984-12-21 | 1989-07-12 | Duphar International Research B.V | New pharmaceutical compositions having anti-psychotic properties |
EP0189612B1 (en) * | 1984-12-21 | 1992-11-04 | Duphar International Research B.V | New pharmaceutical compositions having a psychotropic activity |
US5328905A (en) * | 1987-07-20 | 1994-07-12 | Duphar International Research B.V. | 8,9-anellated-1,2,3,4-tetrahydro-β-carboline derivatives |
ATE136032T1 (de) * | 1987-07-20 | 1996-04-15 | Duphar Int Res | 8,9-anellierte 1,2,3,4-tetrahydro-beta-carbolin- derivate |
US4889852A (en) * | 1987-09-11 | 1989-12-26 | Duphar International Research B.V. | Anxiolytically active piperazine derivatives |
US4992441A (en) * | 1987-10-14 | 1991-02-12 | Mcneilab, Inc. | 1-[[5-[[4-substituted-1-piperazinyl]methyl]-pyrrol-2-yl or furan-2-yl]methyl-2-piperidinones useful in treating schizophrenia |
NZ231631A (en) * | 1988-12-08 | 1992-07-28 | Duphar Int Res | Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions |
GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
EP0380155A1 (en) * | 1989-01-19 | 1990-08-01 | Duphar International Research B.V | 8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives |
US5296497A (en) * | 1989-05-16 | 1994-03-22 | Duphar International Research B.V. | 3,4-dehydropiperidine derivatives having psychotropic activity |
EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
FR2670491B1 (fr) * | 1990-12-14 | 1993-02-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
US5569659A (en) * | 1991-09-11 | 1996-10-29 | Mcneilab, Inc. | 4-arylpiperazines and 4-arylpiperidines |
IE914218A1 (en) * | 1991-09-11 | 1993-03-24 | Mcneilab Inc | Novel 4-arylpiperazines and 4-arylpiperidines |
GB9200293D0 (en) * | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
FR2692264B1 (fr) * | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
DE4219973A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
US5314885A (en) * | 1992-09-11 | 1994-05-24 | Mcneilab, Inc. | Cyclic benzylamino, benzylamido, and benzylimido antipsychotic agents |
US5436246A (en) * | 1992-09-17 | 1995-07-25 | Merrell Dow Pharmaceuticals Inc. | Serotonin receptor agents |
DK148392D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
HU213569B (en) * | 1992-12-21 | 1997-08-28 | Duphar Int Res | Enzymatic process for the stereoselective preparation of a heterobicyclic alcohol enantiomer |
EP0939135A1 (en) * | 1992-12-21 | 1999-09-01 | Duphar International Research B.V | Substantially pure hetero-bicyclic alcohol enantiomers |
US5395936A (en) * | 1993-06-04 | 1995-03-07 | Manzo; Ruben H. | 7-(4-[4-aminophenyl)sulphonyl]-1-piperazinyl fluorquinolonic derivatives and synthesis |
RU2118322C1 (ru) * | 1993-07-05 | 1998-08-27 | Дюфар Интернэшнл Рисерч Б.В. | 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли |
DE4341403A1 (de) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
GB9408872D0 (en) * | 1994-05-03 | 1994-06-22 | Zeneca Ltd | Heterocyclic compounds |
MX9700693A (es) * | 1994-07-26 | 1997-04-30 | Pfizer | Derivados del 4-indol. |
US5998444A (en) * | 1995-10-24 | 1999-12-07 | Zeneca Ltd. | Piperidinyl compounds as NK1 or NK2 antagonists |
EP0709375B1 (en) * | 1994-10-25 | 2005-05-18 | AstraZeneca AB | Therapeutic heterocycles |
US6008223A (en) * | 1994-10-27 | 1999-12-28 | Zeneca Limited | Therapeutic compounds |
GB9508786D0 (en) * | 1995-04-29 | 1995-06-21 | Zeneca Ltd | Substituted heterocycles |
GB9523526D0 (en) * | 1995-11-17 | 1996-01-17 | Zeneca Ltd | Therapeutic compounds |
HU227454B1 (en) | 1996-03-29 | 2011-06-28 | Duphar Int Res | Piperazine and piperidine compounds, process for their preparation and pharmaceutical compositions containing the same |
TW530054B (en) * | 1997-09-24 | 2003-05-01 | Duphar Int Res | New piperazine and piperidine compounds |
FR2769312B1 (fr) * | 1997-10-03 | 1999-12-03 | Adir | Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
UA71590C2 (en) * | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
CA2405758A1 (en) * | 2000-05-12 | 2001-11-15 | Solvay Pharmaceuticals B.V. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
IL152177A0 (en) | 2000-05-12 | 2003-05-29 | Solvay Pharm Bv | Piperazine and piperidine compounds |
AR034206A1 (es) * | 2001-02-16 | 2004-02-04 | Solvay Pharm Bv | Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos |
WO2003007956A1 (en) * | 2001-07-20 | 2003-01-30 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
JP2008075402A (ja) * | 2006-09-25 | 2008-04-03 | Jfe Metal Products & Engineering Inc | 防護柵用ブラケット及び防護柵 |
PL392436A1 (pl) | 2010-09-17 | 2012-03-26 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego |
KR20130132932A (ko) * | 2010-12-20 | 2013-12-05 | 아스트라제네카 아베 | 2-카르복스아미드-4-피페라지닐-벤조푸란 유도체 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2037852C3 (de) * | 1970-07-30 | 1980-06-26 | Boehringer Sohn Ingelheim | Neue Piperazinderivate und Verfahren zu ihrer Herstellung |
US4100173A (en) * | 1974-01-04 | 1978-07-11 | Hoffmann-La Roche Inc. | Dibenz[b,f]oxepin derivatives |
US4062870A (en) * | 1974-05-31 | 1977-12-13 | Beecham Group Limited | Chroman derivatives |
US4091101A (en) * | 1977-06-15 | 1978-05-23 | Merck & Co., Inc. | 6-(1-Piperazinyl)quinoxaline |
US4404383A (en) * | 1979-07-31 | 1983-09-13 | The Quaker Oats Company | N,N'-Bis[5-hydroxymethylfurfuryl]piperazine |
NL8005133A (nl) * | 1980-09-12 | 1982-04-01 | Duphar Int Res | Fenylpiperazinederivaten met antiagressieve werking. |
JPS5777676A (en) * | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
SU1428201A3 (ru) * | 1980-12-18 | 1988-09-30 | Оцука Фармасьютикал Ко.,Лтд (Фирма) | Способ получени бензогетероциклических соединений |
CH653021A5 (fr) * | 1981-04-24 | 1985-12-13 | Delalande Sa | Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant. |
US4355031A (en) * | 1981-05-11 | 1982-10-19 | American Home Products Corp. | 2,3-Dihydro-3-[4-(substituted)-1-piperazinyl]-1H-isoindol-1-ones |
US4426380A (en) * | 1981-10-28 | 1984-01-17 | Ciba-Geigy Corporation | Benzofuran-2-ones and pharmaceutical compositions |
JPS5883677A (ja) * | 1981-11-11 | 1983-05-19 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
JPS5888314A (ja) * | 1981-11-20 | 1983-05-26 | Otsuka Pharmaceut Co Ltd | 強心剤 |
JPS5955878A (ja) * | 1982-09-24 | 1984-03-31 | Chugai Pharmaceut Co Ltd | 新規なフエニルピペラジン誘導体 |
GB2128993B (en) * | 1982-10-08 | 1986-01-15 | Ciba Geigy Ag | Benzofurans |
NZ209876A (en) * | 1983-10-17 | 1988-03-30 | Duphar Int Res | Piperazines and pharmaceutical compositions |
EP0190472B1 (en) * | 1984-12-21 | 1989-07-12 | Duphar International Research B.V | New pharmaceutical compositions having anti-psychotic properties |
EP0189612B1 (en) * | 1984-12-21 | 1992-11-04 | Duphar International Research B.V | New pharmaceutical compositions having a psychotropic activity |
-
1985
- 1985-12-16 EP EP85202086A patent/EP0190472B1/en not_active Expired
- 1985-12-16 EP EP85202081A patent/EP0185429A1/en not_active Withdrawn
- 1985-12-16 AT AT85202086T patent/ATE44528T1/de not_active IP Right Cessation
- 1985-12-16 DE DE8585202086T patent/DE3571436D1/de not_active Expired
- 1985-12-18 NZ NZ214612A patent/NZ214612A/xx unknown
- 1985-12-18 AU AU51390/85A patent/AU589387B2/en not_active Ceased
- 1985-12-18 DK DK590085A patent/DK590085A/da not_active Application Discontinuation
- 1985-12-18 NZ NZ214611A patent/NZ214611A/xx unknown
- 1985-12-18 ZA ZA859664A patent/ZA859664B/xx unknown
- 1985-12-18 ZA ZA859662A patent/ZA859662B/xx unknown
- 1985-12-18 AU AU51392/85A patent/AU5139285A/en not_active Abandoned
- 1985-12-18 ES ES550106A patent/ES8704348A1/es not_active Expired
- 1985-12-18 GR GR853063A patent/GR853063B/el unknown
- 1985-12-18 US US06/810,207 patent/US4782061A/en not_active Expired - Fee Related
- 1985-12-18 GR GR853065A patent/GR853065B/el unknown
- 1985-12-18 IE IE321885A patent/IE58916B1/en not_active IP Right Cessation
- 1985-12-18 DK DK589985A patent/DK589985A/da not_active Application Discontinuation
- 1985-12-19 PH PH33217A patent/PH23958A/en unknown
- 1985-12-19 PH PH33218A patent/PH22040A/en unknown
- 1985-12-19 IL IL77396A patent/IL77396A/xx not_active IP Right Cessation
- 1985-12-20 JP JP60285843A patent/JPS61152666A/ja active Pending
- 1985-12-20 JP JP60285842A patent/JPS61152662A/ja active Pending
-
1987
- 1987-01-29 ES ES557359A patent/ES8802516A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ZA859664B (en) | 1986-08-27 |
PH23958A (en) | 1990-01-23 |
NZ214611A (en) | 1988-06-30 |
IE853218L (en) | 1986-06-21 |
AU5139085A (en) | 1986-07-17 |
ZA859662B (en) | 1986-08-27 |
NZ214612A (en) | 1988-06-30 |
AU589387B2 (en) | 1989-10-12 |
IL77396A (en) | 1990-02-09 |
IE58916B1 (en) | 1993-12-01 |
DE3571436D1 (en) | 1989-08-17 |
EP0190472A1 (en) | 1986-08-13 |
EP0190472B1 (en) | 1989-07-12 |
GR853065B (el) | 1986-04-09 |
DK589985D0 (da) | 1985-12-18 |
PH22040A (en) | 1988-05-13 |
EP0185429A1 (en) | 1986-06-25 |
AU5139285A (en) | 1986-06-26 |
US4782061A (en) | 1988-11-01 |
JPS61152666A (ja) | 1986-07-11 |
ES557359A0 (es) | 1988-07-16 |
ES8802516A1 (es) | 1988-07-16 |
ES550106A0 (es) | 1987-04-01 |
ES8704348A1 (es) | 1987-04-01 |
DK589985A (da) | 1986-06-22 |
ATE44528T1 (de) | 1989-07-15 |
JPS61152662A (ja) | 1986-07-11 |
DK590085D0 (da) | 1985-12-18 |
DK590085A (da) | 1986-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR853065B (el) | ||
AU589732B2 (en) | Process for the preparation of 2-oxo-1,3-dioxolanes | |
AU577928B2 (en) | Labd-14-en-11-one derivatives | |
DE3571982D1 (en) | Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds | |
HUT51485A (en) | Process for production of immune-hindering, monoquin, especially internuclein-1-hindering medical compositions | |
IE882594L (en) | Water-hardening polymer preparation | |
IE781471L (en) | Pyrones | |
GR79111B (el) | ||
ES8705457A1 (es) | Procedimiento para producir nuevos derivados de antibioticosdel grupo de la pluramicina | |
GR3003638T3 (el) | ||
AU574856B2 (en) | Process for the preparation of 4-amino-pyridine-3,5-dicarboxylate compounds | |
PT79025B (en) | Process for the preparation of 1,6-naphthyridin derivatives useful as cardiotonics | |
EP0141354A3 (en) | Compounds useful for combatting swine dysentery and as growth promoting factors, method for the preparation thereof and compositions containing them | |
ES8307739A1 (es) | "procedimiento para la preparacion de nuevos a1-pirrolin-tiolactimeteres". | |
ES8203371A1 (es) | Procedimiento de preparar indolo(2,3,3,4)pirido(2,1-b)quina-zolin-5-onas | |
DE3461189D1 (en) | New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation | |
ZA845668B (en) | Novel process for the preparation of steffimycinone analogs,novel steffimycione analogs thus obtained,novel intermediates which can be used for the synthesis of these compounds,and use of these compounds as antibacterials and for the synthesis of antitumor agents | |
HUT38218A (en) | Process for producing triazolyl-keto-derivatives, as well as fungicidal compositions comprising these compounds |